Synthetic opioids and reducing risk

In this blog post, Turning Point’s Safer Lives Lead, Deb, sheds light on the emergence of a concerning new class of opioids known as “nitazenes” and the risks they present.

We recently shared a joint statement addressing the evolving nature of drugs available in the UK. As an organisation dedicated to supporting individuals facing substance use challenges, we recognise the importance of providing clarification and guidance on these new drugs. 

Deb offers some advice for people using drugs on how they can reduce their risk of overdose and support each other to take charge of their safety.

Find out more by watching our video below:

This blog was originally published by Turning Point. You can read the original post here.

DDN magazine is a free publication self-funded through advertising.

We are proud to work in partnership with many of the leading charities and treatment providers in the sector.

This content was created by Turning Point

We value your input. Please leave a comment, you do not need an account to do this but comments will be moderated before they are displayed...